XS7W:XETRA:XETRA-Xtrackers Portfolio Income UCITS ETF 1D (EUR)

ETF | Others |

Last Closing

USD 13.37

Change

+0.01 (+0.04)%

Market Cap

USD 0.07B

Volume

3.33K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.75 (+1.44%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.25 (+1.48%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.37 (+1.36%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.38 (+1.35%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.34 (+1.38%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+2.74 (+1.90%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.84 (+1.80%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.74 (+1.44%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.59 (+0.61%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.46 (+0.63%)

USD 80.38B

ETFs Containing XS7W:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.40% 42% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.40% 41% F 45% F
Trailing 12 Months  
Capital Gain 12.03% 38% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.03% 38% F 42% F
Trailing 5 Years  
Capital Gain 7.79% 33% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.79% 33% F 36% F
Average Annual (5 Year Horizon)  
Capital Gain 1.29% N/A N/A 35% F
Dividend Return 1.29% N/A N/A 34% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.56% N/A N/A 76% C+
Risk Adjusted Return 17.06% N/A N/A 35% F
Market Capitalization 0.07B 25% F 23% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.